Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -440.15% is 486% below its 5-year average of -75.07%, near the low end of its 5-year range (-440.15%–-11.29%).
As of the fiscal period ended Tuesday, June 30, 2026. 88.62% below its 12-month average of -233.36%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -440.15%.
RETURN ON EQUITY (ROE)
-440.15%
RETURN ON EQUITY (ROE) AVG TTM
-233.36%
RETURN ON EQUITY (ROE) AVG 3Y
-108.73%
RETURN ON EQUITY (ROE) AVG 5Y
-75.07%
RETURN ON EQUITY (ROE) AVG 10Y
N/A
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-88.62%
CURRENT VS 3Y AVG
-304.81%
CURRENT VS 5Y AVG
-486.32%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-38.55%
median of 491 covered companies
CURRENT VS SECTOR MEDIAN
-1041.77%
vs the sector median at left
Ainos, Inc.
Market Cap
$9.65M
Return on Equity (ROE)
-440.15%
TTM Avg
-233.36%
3Y Avg
-108.73%
5Y Avg
-75.07%
Market Cap
$9.56M
Return on Equity (ROE)
-2248.48%
TTM Avg
-970.82%
3Y Avg
-532.13%
5Y Avg
-347.08%
Market Cap
$9.22M
Return on Equity (ROE)
-317.20%
TTM Avg
510.39%
3Y Avg
317.15%
5Y Avg
239.40%
Market Cap
$9.14M
Return on Equity (ROE)
-7.36%
TTM Avg
-85.10%
3Y Avg
-73.72%
5Y Avg
-96.61%
Market Cap
$10.42M
Return on Equity (ROE)
N/A
TTM Avg
18596.99%
3Y Avg
9182.42%
5Y Avg
7349.85%
Market Cap
$10.55M
Return on Equity (ROE)
-506.63%
TTM Avg
-300.20%
3Y Avg
-300.20%
5Y Avg
-300.20%
Market Cap
$10.55M
Return on Equity (ROE)
-252.37%
TTM Avg
-195.20%
3Y Avg
-116.68%
5Y Avg
-90.09%
Market Cap
$10.61M
Return on Equity (ROE)
-85.82%
TTM Avg
-222.53%
3Y Avg
-140.00%
5Y Avg
-73.12%
Market Cap
$8.58M
Return on Equity (ROE)
N/A
TTM Avg
355.89%
3Y Avg
202.91%
5Y Avg
202.91%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Ainos, Inc. (AIMD) | $9.65M | -440.15% | -233.36% | -108.73% | -75.07% |
| Jasper Therapeutics, Inc. (JSPR)vs › | $9.56M | -2248.48% | -970.82% | -532.13% | -347.08% |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.22M | -317.20% | 510.39% | 317.15% | 239.40% |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.14M | -7.36% | -85.10% | -73.72% | -96.61% |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.42M | N/A | 18596.99% | 9182.42% | 7349.85% |
| Caring Brands, Inc. (CABR)vs › | $10.55M | -506.63% | -300.20% | -300.20% | -300.20% |
| Lifeward Ltd. (LFWD)vs › | $10.55M | -252.37% | -195.20% | -116.68% | -90.09% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $10.61M | -85.82% | -222.53% | -140.00% | -73.12% |
| DataMEDS AI, Inc. (MEDS)vs › | $8.58M | N/A | 355.89% | 202.91% | 202.91% |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.53M | -34.67% | 10.89% | 102.13% | 71.00% |
ROE
-440.2%
ROA
-73.9%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -440.15% |
| 2026-03-31 | -244.99% |
| 2025-12-31 | -195.32% |
| 2025-09-30 | -148.90% |
| 2025-06-30 | -137.42% |
| 2025-03-31 | -113.05% |
| 2024-12-31 | -95.79% |
| 2024-09-30 | -89.52% |
| 2024-06-30 | -74.40% |
| 2024-03-31 | -64.22% |
| 2023-12-31 | -56.33% |
| 2023-09-30 | -36.06% |
| 2023-06-30 | -48.78% |
| 2023-03-31 | -44.66% |
| 2022-12-31 | -40.49% |
| 2022-09-30 | -36.59% |
| 2022-06-30 | -111.03% |
| 2022-03-31 | -67.49% |
| 2021-12-31 | -38.13% |
| 2021-09-30 | -16.88% |
| 2021-06-30 | -11.29% |
| 2019-06-30 | -692.38% |
| 2019-03-31 | -278.51% |
| 2018-12-31 | -183.36% |
| 2018-09-30 | -128.79% |
| 2018-06-30 | -164.14% |
| 2018-03-31 | -88.83% |
| 2017-12-31 | -131.13% |
